世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000030681

マイクロニードルドラッグデリバリーシステムの市場規模・シェア・動向分析レポート:タイプ別、材料別、用途別、地域別、およびセグメント予測(2021年〜2028年)

Grand View Research Inc.

Microneedle Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Hollow, Dissolving, Solid, Coated), By Material (Metal, Silicon, Polymer), By Application, By Region, And Segment Forecasts, 2021 - 2028

発刊日 2021/10/18

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000030681

Single
Multiuser
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

マイクロニードルドラッグデリバリーシステム市場の成長と動向

マイクロニードルドラッグデリバリーシステムの世界市場規模は、2028年までに81億ドルに達する見込みです。同市場は、2021年から2028年にかけて、5.3%のCAGRで拡大すると予測されています。従来の皮下注射に代わる安全な方法への需要の高まりや、低侵襲で痛みを伴わない薬剤投与に関する意識の高まりが、市場の成長を後押しすると考えられます。さらに、糖尿病の患者数の増加が市場の成長を後押しすると予想されています。例えば、国際糖尿病連盟(IDF)によると、糖尿病患者数はすでに4億6,300万人に達しており、今後10年間で増加すると予測されています。

マイクロニードルを用いたドラッグデリバリーは、従来の皮下注射に比べて最も効率的な手順の一つです。マイクロニードルは、高い薬物バイオアベイラビリティを持つ経皮的ドラッグデリバリーのための自己投与プラットフォームです。マイクロニードルのデザインと薬剤の配合により、薬剤の投与量、デリバリー速度、有効性をコントロールすることができます。また、マイクロニードルは、バイオハザードのシャープス廃棄物の削減・解消にも役立ちます。今後数年間で、マイクロニードルは臨床治療に大きな影響を与えることが予想されます。

マイクロニードルは現在も開発中で、臨床試験ではさまざまな薬剤が使用されています。大半の研究では、この手法がポジティブな効果を生むことが示されています。この手法は、さまざまな分野で治療目的に使用される可能性があります。例えば、カーネギーメロン大学では、3Dプリントされたハイブリッドマイクロニードルアレイ(Hybrid-MNA)を採用したCOVID-19ワクチン注射法を開発しています。Hybrid-MNAのアプローチは、低用量を可能にするだけでなく、痛みを伴わず、自己投与の可能性も秘めています。これらの技術により、マイクロニードルをより安価に製造することが可能になると予測されます。マイクロニードルは、ワクチン投与、ホルモン投与、癌治療、疼痛管理、化粧品など、幅広い用途があります。

マイクロニードルドラッグデリバリーシステム市場レポートのハイライト

  • 中空タイプのセグメントは、ワクチンやホルモン療法を受ける患者の使用に最適とされているため、2020年には最大の収益シェアを占めました。
  • 溶解タイプのセグメントは、1つのステップしか必要とせず、挿入後にマイクロニードルを取り外す必要がないため、予測期間中に最も速い速度で成長すると予想されます。
  • 2020年には、金属材料セグメントが最大の収益シェアを占めました。ステンレスとチタンが最も多く採用されている金属です。
  • 用途別に見ると、2020年にはドラッグデリバリー分野が市場を独占しました。ワクチンデリバリー分野は、人口の間でワクチン接種に関する意識が高まっていることから、予測期間中に最も速い成長率を記録すると予想されています。
  • アジア太平洋地域は、中国やインドなどの新興国に未開拓の機会があるため、予測期間中に最も速いCAGRで拡大すると予想されます。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Material
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Material outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Microneedle Drug Delivery Systems Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. The increasing demand for a safer substitute to conventional hypodermic injections
3.4.1.2. Increase in diabetic cases across the globe
3.4.1.3. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. Limited number of approved products
3.4.2.2. Complications/risks associated with microneedles
3.5. Microneedle Drug Delivery Systems Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies

Chapter 4. Microneedle Drug Delivery Systems: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Solid
4.1.2. Hollow
4.1.3. Dissolving
4.1.4. Coated
4.1.5. Others
4.2. Type Market Share, 2020 & 2028
4.3. Segment Dashboard
4.4. Global Microneedle Drug Delivery Systems Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Solid
4.5.1.1. Solid market estimates and forecast 2016 to 2028 (USD Million)
4.5.2. Hollow
4.5.2.1. Hollow market estimates and forecast 2016 to 2028 (USD Million
4.5.3. Dissolving
4.5.3.1. Dissolving market estimates and forecast 2016 to 2028 (USD Million)
4.5.4. Coated
4.5.4.1. Coated market estimates and forecast 2016 to 2028 (USD Million)
4.5.5. Others
4.5.5.1. Others market estimates and forecast 2016 to 2028 (USD Million)

Chapter 5. Microneedle Drug Delivery Systems: Material Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Silicon
5.1.2. Metal
5.1.3. Polymer
5.1.4. Others
5.2. Material Market Share, 2020 & 2028
5.3. Segment Dashboard
5.4. Global Microneedle Drug Delivery Systems Market by Material Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Silicon
5.5.1.1. Silicon market estimates and forecast 2016 to 2028 (USD million)
5.5.2. Metal
5.5.2.1. Metal market estimates and forecast 2016 to 2028 (USD Million)
5.5.3. Polymer
5.5.3.1. Polymer market estimates and forecast 2016 to 2028 (USD million)
5.5.4. Others
5.5.4.1. Others market estimates and forecast 2016 to 2028 (USD million)

Chapter 6. Microneedle Drug Delivery Systems: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Dermatology
6.1.2. Drug delivery
6.1.3. Pain management
6.1.4. Cancer therapy
6.1.5. Vaccine delivery
6.1.6. Others
6.2. Material Market Share, 2020 & 2028
6.3. Segment Dashboard
6.4. Global Microneedle Drug Delivery Systems Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.5.1. Dermatology
6.5.1.1. Dermatology market estimates and forecast 2016 to 2028 (USD million)
6.5.2. Hormone delivery
6.5.2.1. Hormone delivery market estimates and forecast 2016 to 2028 (USD Million)
6.5.3. Pain management
6.5.3.1. Pain management market estimates and forecast 2016 to 2028 (USD million)
6.5.4. Cancer therapy
6.5.4.1. Cancer therapy market estimates and forecast 2016 to 2028 (USD Million)
6.5.5. Vaccine delivery
6.5.5.1. Vaccine delivery market estimates and forecast 2016 to 2028 (USD Million)
6.5.6. Others
6.5.6.1. Others market estimates and forecast 2016 to 2028 (USD Million)

Chapter 7. Microneedle Drug Delivery Systems Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2020 & 2028
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2016 to 2028:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.8. Europe
7.8.1. U.K.
7.8.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. China
7.9.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.9.2. Japan
7.9.2.1. Market estimates and forecast, 2016 - 2028 (Volume, Thousand)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.9.4. Thailand
7.9.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.9.5. South Korea
7.9.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.10.4. Colombia
7.10.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.11.2. South Africa
7.11.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.3.4. Raphas
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Novartis International AG
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Becton, Dickinson and Company
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. B. Braun
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Nanopass Technologies Limited
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Termo
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Smiths Medical
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Cardinal Health
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. 3M
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviation
Table 2 North America microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 3 North America microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 4 North America microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 5 North America microneedle drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 6 U.S. microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 7 U.S. microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 8 U.S. microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 9 Canada microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 10 Canada microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 11 Canada microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 12 Europe microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 13 Europe microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 14 Europe microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 15 Europe microneedle drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 16 Germany microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 17 Germany microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 18 Germany microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 19 U.K. microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 20 U.K. microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 21 U.K. microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 22 France microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 23 France microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 24 France microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 25 Italy microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 26 Italy microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 27 Italy microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 28 Spain microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 29 Spain microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 30 Spain microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 31 APAC microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 32 APAC microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 33 APAC microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 34 APAC microneedle drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 35 China microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 36 China microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 37 China microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 38 Japan microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 39 Japan microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 40 Japan microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 41 India microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 42 India microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 43 India microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 44 Thailand microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 45 Thailand microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 46 Thailand microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 47 South Korea microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 48 South Korea microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 49 South Korea microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 50 Latin America microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 51 Latin America microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 52 Latin America microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 53 Latin America microneedle drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 54 Brazil microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 55 Brazil microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 56 Brazil microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 57 Mexico microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 58 Mexico microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 59 Mexico microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 60 Argentina microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 61 Argentina microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 62 Argentina microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 63 Colombia microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 64 Colombia microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 65 Colombia microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 66 Middle East and Africa microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 67 Middle East and Africa microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 68 Middle East and Africa microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 69 Middle East and Africa microneedle drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 70 South Africa microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 71 South Africa microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 72 South Africa microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 73 Saudi Arabia microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 74 Saudi Arabia microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 75 Saudi Arabia microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)
Table 76 UAE microneedle drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 77 UAE microneedle drug delivery systems market, by material, 2016 - 2028 (USD Million)
Table 78 UAE microneedle drug delivery systems market, by application, 2016 - 2028 (USD Million)

List of Figure
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Microneedle Drug Delivery Systems : market outlook
Fig. 14 Microneedle Drug Delivery Systems competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Microneedle drug delivery systems market driver impact
Fig. 20 Microneedle drug delivery systems market restraint impact
Fig. 21 Microneedle drug delivery systems market strategic initiatives analysis
Fig. 22 Microneedle drug delivery systems market: type movement analysis
Fig. 23 Microneedle drug delivery systems market: type outlook and key takeaways
Fig. 24 Solid market estimates and forecast, 2016 - 2028
Fig. 25 Hollow market estimates and forecast, 2016 - 2028
Fig. 26 Dissolving market estimates and forecast, 2016 - 2028
Fig. 27 Coated market estimates and forecast, 2016 - 2028
Fig. 28 Others market estimates and forecast, 2016 - 2028
Fig. 29 Microneedle drug delivery systems market: material movement analysis
Fig. 30 Microneedle drug delivery systems market: material outlook and key takeaways
Fig. 31 Silicon market estimates and forecast, 2016 - 2028
Fig. 32 Metal market estimates and forecast, 2016 - 2028
Fig. 33 Polymer market estimates and forecast, 2016 - 2028
Fig. 34 Others market estimates and forecast, 2016 - 2028
Fig. 35 Microneedle drug delivery systems market: application movement analysis
Fig. 36 Microneedle drug delivery systems market: application outlook and key takeaways
Fig. 37 Dermatology market estimates and forecast, 2016 - 2028
Fig. 38 Drug delivery market estimates and forecast, 2016 - 2028
Fig. 39 Pain management market estimates and forecast, 2016 - 2028
Fig. 40 Cancer therapy market estimates and forecast, 2016 - 2028
Fig. 41 Vaccine delivery market estimates and forecast, 2016 - 2028
Fig. 42 Others market estimates and forecast, 2016 - 2028
Fig. 43 Global microneedle drug delivery systems market: regional movement analysis
Fig. 44 Global microneedle drug delivery systems market: regional outlook and key takeaways
Fig. 45 Global market share and leading players
Fig. 46 North America market share and leading players
Fig. 47 Europe market share and leading players
Fig. 48 Asia Pacific market share and leading players
Fig. 49 Latin America market share and leading players
Fig. 50 Middle East & Africa market share and leading players
Fig. 51 North America: SWOT
Fig. 52 Europe SWOT
Fig. 53 Asia Pacific SWOT
Fig. 54 Latin America SWOT
Fig. 55 MEA SWOT
Fig. 56 North America, by country
Fig. 57 North America
Fig. 58 North America market estimates and forecast, 2016 - 2028
Fig. 59 U.S.
Fig. 60 U.S. market estimates and forecast, 2016 - 2028
Fig. 61 Canada
Fig. 62 Canada market estimates and forecast, 2016 - 2028
Fig. 63 Europe
Fig. 64 Europe market estimates and forecast, 2016 - 2028
Fig. 65 U.K.
Fig. 66 U.K. market estimates and forecast, 2016 - 2028
Fig. 67 Germany
Fig. 68 Germany market estimates and forecast, 2016 - 2028
Fig. 69 France
Fig. 70 France market estimates and forecast, 2016 - 2028
Fig. 71 Italy
Fig. 72 Italy market estimates and forecast, 2016 - 2028
Fig. 73 Spain
Fig. 74 Spain market estimates and forecast, 2016 - 2028
Fig. 75 Asia Pacific
Fig. 76 Asia Pacific market estimates and forecast, 2016 - 2028
Fig. 77 China
Fig. 78 China market estimates and forecast, 2016 - 2028
Fig. 79 Japan
Fig. 80 Japan market estimates and forecast, 2016 - 2028
Fig. 81 India
Fig. 82 India market estimates and forecast, 2016 - 2028
Fig. 83 Thailand
Fig. 84 Thailand market estimates and forecast, 2016 - 2028
Fig. 85 South Korea
Fig. 86 South Korea market estimates and forecast, 2016 - 2028
Fig. 87 Latin America
Fig. 88 Latin America market estimates and forecast, 2016 - 2028
Fig. 89 Brazil
Fig. 90 Brazil market estimates and forecast, 2016 - 2028
Fig. 91 Mexico
Fig. 92 Mexico market estimates and forecast, 2016 - 2028
Fig. 93 Argentina
Fig. 94 Argentina market estimates and forecast, 2016 - 2028
Fig. 95 Colombia
Fig. 96 Colombia market estimates and forecast, 2016 - 2028
Fig. 97 Middle East and Africa
Fig. 98 Middle East and Africa. market estimates and forecast, 2016 - 2028
Fig. 99 Saudi Arabia
Fig. 100 Saudi Arabia market estimates and forecast, 2016 - 2028
Fig. 101 South Africa
Fig. 102 South Africa market estimates and forecast, 2016 - 2028
Fig. 103 UAE
Fig. 104 UAE market estimates and forecast, 2016 - 2028
Fig. 105 Participant categorization- Microneedle Drug Delivery Systems market
Fig. 106 Market share of key market players- Microneedle drug delivery systems market

この商品のレポートナンバー

0000030681

TOP